Trial no.:
|
PACTR202203828186104 |
Date of Registration:
|
30/03/2022 |
Trial Status:
|
Registered in accordance with WHO and ICMJE standards |
|
TRIAL DESCRIPTION |
Public title
|
INFLEUNCE OF SCHROTH THERAPY ON VENTILATORY FUNCTION IN ADOLESCENT IDIOPATHIC SCOLIOSIS |
Official scientific title |
INFLEUNCE OF SCHROTH THERAPY ON VENTILATORY FUNCTION IN ADOLESCENT IDIOPATHIC SCOLIOSIS |
Brief summary describing the background
and objectives of the trial
|
Nonsurgical treatment options are commonly advocated, but no
evidence to discriminate between these methods is presented (Everett &
Patel, 2007). Currently, a lack of consensus exists on the most efficacious
conservative clinical treatment for AIS. The objective is to evaluate the evidence of effectiveness of potential conservative treatment options in AIS (Negrini et al., 2006).
Respiratory disorders and exercise intolerance are common complications of AIS secondary to weakness of respiratory muscles and reduced lung capacity (Martinez-Liorens et al., 2010)
Does Schroth exercises affect pulmonary function in adolescent idiopathic scoliosis? |
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Musculoskeletal Diseases |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Education /Training |
Anticipated trial start date |
01/04/2022 |
Actual trial start date |
01/04/2022 |
Anticipated date of last follow up |
01/10/2022 |
Actual Last follow-up date |
31/12/2023 |
Anticipated target sample size (number of participants) |
60 |
Actual target sample size (number of participants) |
60 |
Recruitment status |
Active, not recruiting |
Publication URL |
|
|